184 related articles for article (PubMed ID: 29023613)
1. Comparative Study of rhPDGF-BB Plus Equine-Derived Bone Matrix Versus rhPDGF-BB Plus β-TCP in the Treatment of Periodontal Defects.
Lee JY; Na HJ; Kim HM; Lee SC; Lee JY; Chung CP; Seol YJ; Park YJ
Int J Periodontics Restorative Dent; 2017; 37(6):825-832. PubMed ID: 29023613
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
3. Treatment of periodontal intrabony defects using β-TCP alone or in combination with rhPDGF-BB: a randomized controlled clinical and radiographic study.
Maroo S; Murthy KR
Int J Periodontics Restorative Dent; 2014; 34(6):841-7. PubMed ID: 25411740
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β-TCP for the treatment of infrabony periodontal defects: clinical and radiographic results.
Thakare K; Deo V
Int J Periodontics Restorative Dent; 2012 Dec; 32(6):689-96. PubMed ID: 23057058
[TBL] [Abstract][Full Text] [Related]
5. New composite endpoints to assess efficacy in periodontal therapy clinical trials.
Lynch SE; Lavin PT; Genco RJ; Beasley WG; Wisner-Lynch LA
J Periodontol; 2006 Aug; 77(8):1314-22. PubMed ID: 16881800
[TBL] [Abstract][Full Text] [Related]
6. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.
Nevins M; Camelo M; Nevins ML; Schenk RK; Lynch SE
J Periodontol; 2003 Sep; 74(9):1282-92. PubMed ID: 14584860
[TBL] [Abstract][Full Text] [Related]
7. The combination of purified recombinant human platelet-derived growth factor-BB and equine particulate bone graft for periodontal regeneration.
Nevins M; Nevins ML; Karimbux N; Kim SW; Schupbach P; Kim DM
J Periodontol; 2012 May; 83(5):565-73. PubMed ID: 22014175
[TBL] [Abstract][Full Text] [Related]
8. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.
Jayakumar A; Rajababu P; Rohini S; Butchibabu K; Naveen A; Reddy PK; Vidyasagar S; Satyanarayana D; Pavan Kumar S
J Clin Periodontol; 2011 Feb; 38(2):163-72. PubMed ID: 21133980
[TBL] [Abstract][Full Text] [Related]
9. Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defects.
Ridgway HK; Mellonig JT; Cochran DL
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):171-9. PubMed ID: 18546813
[TBL] [Abstract][Full Text] [Related]
10. Growth factor-mediated treatment of recession defects: a randomized controlled trial and histologic and microcomputed tomography examination.
McGuire MK; Scheyer ET; Schupbach P
J Periodontol; 2009 Apr; 80(4):550-64. PubMed ID: 19335074
[TBL] [Abstract][Full Text] [Related]
11. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations.
McGuire MK; Kao RT; Nevins M; Lynch SE
Int J Periodontics Restorative Dent; 2006 Jun; 26(3):223-31. PubMed ID: 16836164
[TBL] [Abstract][Full Text] [Related]
12. Growth factors and beta-tricalcium phosphate in the treatment of periodontal intraosseous defects: A systematic review and meta-analysis of randomised controlled trials.
Cãlin C; Pãtraşcu I
Arch Oral Biol; 2016 Jun; 66():44-54. PubMed ID: 26897256
[TBL] [Abstract][Full Text] [Related]
13. Stem Cells Cultured on Beta Tricalcium Phosphate (β-TCP) in Combination with Recombinant Human Platelet-Derived Growth Factor - BB (rh-PDGF-BB) for the Treatment of Human Infrabony Defects.
Dhote R; Charde P; Bhongade M; Rao J
J Stem Cells; 2015; 10(4):243-54. PubMed ID: 27144828
[TBL] [Abstract][Full Text] [Related]
14. Growth/differentiation factor-5 significantly enhances periodontal wound healing/regeneration compared with platelet-derived growth factor-BB in dogs.
Kwon HR; Wikesjö UM; Park JC; Kim YT; Bastone P; Pippig SD; Kim CK
J Clin Periodontol; 2010 Aug; 37(8):739-46. PubMed ID: 20618546
[TBL] [Abstract][Full Text] [Related]
15. Prospective Randomized Controlled Trial of Hindfoot and Ankle Fusions Treated With rhPDGF-BB in Combination With a β-TCP-Collagen Matrix.
Daniels TR; Younger AS; Penner MJ; Wing KJ; Le IL; Russell IS; Lalonde KA; Evangelista PT; Quiton JD; Glazebrook M; DiGiovanni CW
Foot Ankle Int; 2015 Jul; 36(7):739-48. PubMed ID: 25848134
[TBL] [Abstract][Full Text] [Related]
16. Single versus double flap approach in periodontal regenerative treatment.
Schincaglia GP; Hebert E; Farina R; Simonelli A; Trombelli L
J Clin Periodontol; 2015 Jun; 42(6):557-66. PubMed ID: 25924545
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous injection of augment injectable bone graft (rhPDGF-BB and β-tricalcium phosphate [β-TCP]/bovine type I collagen matrix) increases vertebral bone mineral density in geriatric female baboons.
Perrien DS; Young CS; Alvarez-Urena PP; Dean DD; Lynch SE; Hollinger JO
Spine J; 2013 May; 13(5):580-6. PubMed ID: 23541446
[TBL] [Abstract][Full Text] [Related]
18. Effect of rhPDGF-BB on bone turnover during periodontal repair.
Sarment DP; Cooke JW; Miller SE; Jin Q; McGuire MK; Kao RT; McClain PK; McAllister BS; Lynch SE; Giannobile WV
J Clin Periodontol; 2006 Feb; 33(2):135-40. PubMed ID: 16441739
[TBL] [Abstract][Full Text] [Related]
19. Release, biological potency, and biochemical integrity of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) combined with Augment(TM) Bone Graft or GEM 21S beta-tricalcium phosphate (beta-TCP).
Young CS; Ladd PA; Browning CF; Thompson A; Bonomo J; Shockley K; Hart CE
J Control Release; 2009 Dec; 140(3):250-5. PubMed ID: 19577598
[TBL] [Abstract][Full Text] [Related]
20. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
